TIL · Instil Bio, Inc.
$7.86
+0.03 (+0.38%)
At close · Aug 27
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“the 2024 Loan is due in January 2027, for total principal of $85.6 million, which is in excess of cash, cash equivalents, and marketable securities on hand as of June 30, 2026, which we concluded is an indicator of substantial doubt about our ability to continue as a going concern. ... We concluded that management's plans, including Complex Therapeutics LLC's contractual right to exercise the extension option to January 2028, which is within Complex Therapeutics LLC's control, alleviate the conditions that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.10M
Shares
6.78M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-11 | |
| 8-K | 2026-04-03 | 2026-04-01 | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-01-06 | 2026-01-05 | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-27 | 2025-05-22 | |
| 8-K | 2025-05-22 | — | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-14 | 2025-05-28 | |
| 8-K | 2025-03-31 | 2025-03-28 | |
| 10-K | 2025-03-04 | 2024-12-31 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-12-23 | 2024-12-20 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-09-16 | — | |
| 8-K | 2024-09-06 | 2024-09-01 | |
| 8-K | 2024-08-15 | — | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-01 | — | |
| 8-K | 2024-07-11 | 2024-07-10 | |
| 8-K | 2024-06-17 | 2024-06-13 | |
| 8-K | 2024-05-10 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-13 | |
| 8-K | 2024-04-26 | 2024-04-24 | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-02-14 | 2024-02-12 | |
| 8-K | 2024-01-18 | 2024-01-17 | |
| 8-K | 2024-01-16 | 2024-01-14 | |
| 8-K | 2023-12-08 | 2023-12-07 | |
| 8-K | 2023-11-27 | 2023-11-21 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 10-Q/A | 2023-11-13 | 2023-09-30 |
Showing 1–50 of 95 filings
Key facts
CIK
1789769
CUSIP
45783C200
13F (30d)
25 filings
25 filers
Visit website
Investor relations